Molecular Analysis of Goodpasture's Disease Following Hematopoietic Stem Cell Transplant in a Pediatric Patient, Recalls the Conformeropathy of Wild-Type Anti-GBM Disease
Authors: Paul E Gray, Hugh McCarthy, Owen M Siggs, Moin A Saleem, Tracy O' Brien, Katie Frith, John B Ziegler, A Richard Kitching, Agnes B Fogo, Billy G Hudson, Vadim Pedchenko
Journal: Front Immunol (2019)
Keywords: goodpastures, gvhd, alloimmunity, anti-gbm, autoimmunity, conformeropathy, glomerular basement membrane
MeSH terms: Anti-Glomerular Basement Membrane Disease / immunology, Autoantibodies / immunology, Autoantigens / immunology, Collagen Type IV / immunology, Hematopoietic Stem Cell Transplantation / adverse effects, Case Reports, Research Support, N.I.H., Extramural, Allografts, Anti-Glomerular Basement Membrane Disease / etiology, Child, Collagen Type IV / genetics, Epitopes / immunology, Humans, Isoantibodies / immunology, Lymphoproliferative Disorders / therapy, Male, Postoperative Complications / etiology, Postoperative Complications / immunology, Autoantibodies, Autoantigens, Collagen Type IV, Epitopes, Isoantibodies, antiglomerular basement membrane antibody

Background: Goodpasture's disease (GP) is mediated by autoantibodies that bind the glomerular and alveolar basement membrane, causing rapidly progressive glomerulonephritis with or without pulmonary hemorrhage. The autoantibodies bind neoepitopes formed upon disruption of the quaternary structure of α345NC1 hexamer, a critical structural domain of α345 collagen IV scaffolds. Hexamer disruption leads to a conformational changes that transitions α3 and α5NC1 subunits into immunogens, however, the trigger remains unknown. This contrasts with another anti-GBM disease, Alports' post-transplant nephritis (APTN), where the pathogenic alloantibody binds directly to native NC1 hexamer. The current report includes the first study of antigenic specificity and allo-incompatability in anti-GBM disease occurring after allogeneic haematopoietic stem cell transplant (HSCT). Results: The anti-GBM antibodies were found to be directed predominantly against the EA epitope of the α3 NC1 monomer of collagen IV and developed rapidly in patient serum reaching peak level within 5 weeks. Autoantibody binding to native α345NC1 hexamer was minimal; however, binding was greatly increased upon dissociation of the native hexamer. There were no polymorphic genetic differences between donor and recipient collagen IV genes which would be predicted to cause a significant NC1 conformational change or to provide a target for antibody binding. Both patient and donor possessed the Goodpasture's susceptibility HLA-allele DRB1*1501. Conclusions: The current report includes the first in-depth study of allo-incompatability and antigenic specificity in anti-GBM disease occurring after allogeneic haematopoietic stem cell transplant (HSCT). No polymorphic genetic differences were identified between donor and recipient collagen IV genes which would be predicted to provide a target for antibody binding. Furthermore, autoantibody binding to native α345NC1 hexamer was minimal, increasing greatly upon dissociation of the native hexamer, resembling wild-type GP diseases and marking this as the first example of a post-HSCT conformeropathy.